Here are seven points:
1. The stock was sold at an average price of $99 per share, and the transaction totaled $1.18 million.
2. Ms. Stryker now directly owns 192,194 shares of the company’s stock, valued at $19.02 million.
3. This transaction comes on the heels of Stryker’s $2.7 billion acquisition of Sage Products. Moody’s Investors Service placed Stryker’s A3 unsecured note ratings on review for downgrade just last week.
4. In December 2015, Ms. Stryker sold 18,000 shares of the company following rumors that Stryker is once again planning to make a bid for Smith & Nephew.
5. Stryker has a 12-month low of $86.68 and a 12-month high of $105.34.
6. The company’s 50-day moving average is $93.42, and its 200-day moving average is $96.75.
7. Stryker has a market cap of $36.27 billion.
More articles on devices:
Smith & Nephew, Zimmer Biomet, Medovex & more: 20 key notes
Global non-fusion spinal device market to grow: 3 points
Medtech sells 2 ROSA Brain robots in US: 3 quick notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
